Fred E Cooperrider

Array ( [id] => 4167293 [patent_doc_number] => 06140072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Functional recombinantly prepared synthetic protein polymer' [patent_app_type] => 1 [patent_app_number] => 8/475411 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39510 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140072.pdf [firstpage_image] =>[orig_patent_app_number] => 475411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3704479 [patent_doc_number] => 05674995 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Oligonucleotides specific for cytokine signal transducer gp130 mRNA' [patent_app_type] => 1 [patent_app_number] => 8/476634 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5853 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674995.pdf [firstpage_image] =>[orig_patent_app_number] => 476634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297870 [patent_doc_number] => 06184348 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Functional recombinantly prepared synthetic protein polymer' [patent_app_type] => 1 [patent_app_number] => 8/478029 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21897 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184348.pdf [firstpage_image] =>[orig_patent_app_number] => 478029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4246057 [patent_doc_number] => 06221661 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Hairpin ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/476423 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 74 [patent_no_of_words] => 28769 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221661.pdf [firstpage_image] =>[orig_patent_app_number] => 476423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002179 [patent_doc_number] => 06004806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Optimized minizymes and miniribozymes and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/488181 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 15625 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004806.pdf [firstpage_image] =>[orig_patent_app_number] => 488181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3863143 [patent_doc_number] => 05795964 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Lymphotoxin-beta and lymphotoxin-beta complexes' [patent_app_type] => 1 [patent_app_number] => 8/467070 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 31 [patent_no_of_words] => 21952 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795964.pdf [firstpage_image] =>[orig_patent_app_number] => 467070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099441 [patent_doc_number] => 06066501 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'D-type cyclin and uses related thereto' [patent_app_type] => 1 [patent_app_number] => 8/463772 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 37170 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066501.pdf [firstpage_image] =>[orig_patent_app_number] => 463772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805402 [patent_doc_number] => 05854055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Recombinant mycobacteria' [patent_app_type] => 1 [patent_app_number] => 8/463942 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 20517 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854055.pdf [firstpage_image] =>[orig_patent_app_number] => 463942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3963740 [patent_doc_number] => 05885796 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'CTLA4 receptor and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/465078 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 43 [patent_no_of_words] => 26045 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885796.pdf [firstpage_image] =>[orig_patent_app_number] => 465078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407033 [patent_doc_number] => 06265173 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Methods of modulating the expression of genes using ultraspiracle receptor' [patent_app_type] => 1 [patent_app_number] => 8/464514 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 14640 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265173.pdf [firstpage_image] =>[orig_patent_app_number] => 464514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4060040 [patent_doc_number] => 05864028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Degradation resistant mRNA derivatives linked to TNF-.alpha. ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/464073 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 79 [patent_no_of_words] => 21945 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/864/05864028.pdf [firstpage_image] =>[orig_patent_app_number] => 464073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089124 [patent_doc_number] => 06133242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes' [patent_app_type] => 1 [patent_app_number] => 8/461366 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 32 [patent_no_of_words] => 15300 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133242.pdf [firstpage_image] =>[orig_patent_app_number] => 461366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3999694 [patent_doc_number] => 05858773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Regulatory nucleotide sequence of the initiation of transcription' [patent_app_type] => 1 [patent_app_number] => 8/461775 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5672 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858773.pdf [firstpage_image] =>[orig_patent_app_number] => 461775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3734023 [patent_doc_number] => 05698426 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Surface expression libraries of heteromeric receptors' [patent_app_type] => 1 [patent_app_number] => 8/464136 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14968 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698426.pdf [firstpage_image] =>[orig_patent_app_number] => 464136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3767044 [patent_doc_number] => 05773260 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Ribozyme compositions and expression vectors' [patent_app_type] => 1 [patent_app_number] => 8/458404 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5914 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773260.pdf [firstpage_image] =>[orig_patent_app_number] => 458404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693289 [patent_doc_number] => 05650295 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Macrophage migration inhibitory factor-3' [patent_app_type] => 1 [patent_app_number] => 8/460528 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10199 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650295.pdf [firstpage_image] =>[orig_patent_app_number] => 460528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4400242 [patent_doc_number] => 06270776 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Recombinant mycobacterial vaccine' [patent_app_type] => 1 [patent_app_number] => 8/454075 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 20466 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/270/06270776.pdf [firstpage_image] =>[orig_patent_app_number] => 454075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940316 [patent_doc_number] => 05973110 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Cytotoxic T-lymphocyte antigen as cysteine protease inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/373215 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 8938 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/973/05973110.pdf [firstpage_image] =>[orig_patent_app_number] => 373215 [rel_patent_id] =>[rel_patent_doc_number] =>)